0001802806-24-000041.txt : 20241004 0001802806-24-000041.hdr.sgml : 20241004 20241004160307 ACCESSION NUMBER: 0001802806-24-000041 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241004 DATE AS OF CHANGE: 20241004 EFFECTIVENESS DATE: 20241004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CERO THERAPEUTICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001870404 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 871088814 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-525940 FILM NUMBER: 241354890 BUSINESS ADDRESS: STREET 1: 201 HASKINS WAY STREET 2: SUITE 230 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-407-2376 MAIL ADDRESS: STREET 1: 201 HASKINS WAY STREET 2: SUITE 230 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: PHOENIX BIOTECH ACQUISITION CORP. DATE OF NAME CHANGE: 20210630 D 1 primary_doc.xml X0708 D LIVE 0001870404 CERO THERAPEUTICS HOLDINGS, INC. 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-407-2376 DELAWARE PHOENIX BIOTECH ACQUISITION CORP. Corporation true 2021 Brian Atwood 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Director CEO at time of agreement, now former CEO but a continuing director Andrew Albert Kucharchuk 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Executive Officer Chief Financial Officer Kristen Pierce 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Executive Officer Chief Development Officer Michael Byrnes 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Director Chris Ehrlich 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Interim Chairman and CEO Kathleen LaPorte 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Director Lindsey Rolfe 201 Haskins Way, Suite 230 South San Francisco CA CALIFORNIA 94080 Director Pharmaceuticals No Revenues 06b false 2024-09-26 false true true true false 1000 1250000 1250000 0 false 13 0 0 0 false CERO THERAPEUTICS HOLDINGS, INC. /s/ Al Kucharchuk Al Kucharchuk CFO 2024-10-04